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Versatile new paradigm for the design of optical nanosensors 
based on enzyme-mediated detachment of labelled-reporters: The 
example of urea detection 
Antoni Llopis-Lorente,[a,b,c] Reynaldo Villalonga,*[d] M. Dolores Marcos,[a,b,c,e,f] Ramón Martínez-
Máñez*[a,b,c,e,f] and Félix Sancenón[a,b,c,e,f] 
 
Abstract: Here we present a novel bio-inspired nanoarchitectonics 
approach for the design of optical probes. It is based on 
nanodevices that combine (i) an enzymatic receptor subunit, (ii) a 
signalling subunit (consisting of a labelled-reporter attached to a 
silica surface), and (iii) a mechanism of communication between the 
two sites founded on the production of chemical messengers by the 
enzymatic subunit that induces the detachment of the reporter 
molecules from the silica surface. As a proof of concept, a urea 
nanosensor based on the release of Alexa Fluor 647-labelled 
oligonucleotide from enzyme-functionalized Janus Au-MSNPs (gold-
mesoporous silica nanoparticles) has been developed. Janus Au-
MSNPs are functionalized on the silica face with amino groups to 
which the labelled oligonucleotide is attached by electrostatic 
interactions, whereas the gold face is used for grafting the urease 
enzyme. The nanodevice is able to release fluorescent-
oligonucleotide via enzyme-mediated hydrolysis of urea to ammonia 
and the subsequent deprotonation of amino groups on the silica face. 
This simple nanodevice has been applied for the flurorimetric 
detection of urea in real human blood samples and for the 
identification of adulterated milk. Given the large variety of enzymes 
and reporter species that could be combined, we believe this is a 
general new paradigm that could applied to the design of a number 
of optical probes for the detection of target analytes. 
Introduction 
The chromo-fluorogenic detection of analytes (cations, 
anions and neutral molecules) of biomedical and environmental 
interest is a primary research topic due to their potential 
applications in different fields.[1] Chromo-fluorogenic probes 
(also called chemosensors) offer certain advantages such as no 
need to use sophisticated equipment or highly-trained personnel, 
low cost, rapid response and in-situ detection.[2] Most 
chemosensors are usually molecular entities that incorporate (i) 
a receptor subunit (that interacts with analyte), (ii) a signalling 
subunit (usually a fluoro-chromophore group) and (iii) a 
mechanism of communication between the two subunits (e.g. 
photinduced electron transfer (PET), electronic energy transfer 
(EET), etc.) (Figure 1a).[3] A key step when designing an optical 
probe is to find the receptor group that interacts specifically with 
the target analyte. 
 
 
Figure 1. a) Schematic of a typical chromo-fluorogenic probe containing a 
receptor subunit and a signalling subunit. b) Schematic of the bio-inspired 
nanoarchitectonics approach proposed in this paper for the design of 
nanosensors combining an enzymatic receptor subunit and a hybrid signalling 
subunit. 
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When talking about chromo-fluorogenic chemosensors, the 
design of probes for small neutral biomolecules is challenging 
due to their lower reactivity compared to cations and anions. In 
natural systems, recognition of small biomolecules is 
accomplished by antibodies, enzymes and other bioreceptors.[4] 
Whereas antibodies bind to the target molecule, enzymes 
transform their specific substrates into new chemicals. On the 
other hand, nanoarchitectonics has been regarded as a 
promising approach to develop advanced nanoscale materials 
based on the synergic combination of different nano-(bio)-
components using nanotechnology, supramolecular and 
molecular chemistry, and bio-related technologies.[5] Inspired by 
both traditional chemosensors and the role of enzymes in living 
systems, we envisioned a new versatile paradigm for the design 
of  optical probes based on hybrid nanodevices incorporating (i) 
enzymes as receptor subunit, (ii) fluoro-chromogenic species 
linked to a silica surface as the signalling subunit and (iii) a 
mechanism of communication between the two subunits based 
on the production of “chemical messengers” by the enzymes 
that induce the detachment and release of the fluoro-
chromophore. As proof of concept, we present here a urea 
nanosensor based on Janus Au-MSNPs (gold-mesoporous silica 
nanoparticles) functionalized with Alexa Fluor 647-labelled 
oligonucleotide on the silica surface and with urease on the gold 
surface (Figure 2). 
In the scientific literature, the term Janus is used to define 
particles that have two (or more) surfaces with different chemical 
and physical properties.[6] Janus particles with different 
morphologies and 3D architectures have been designed such as 
half-and-half hemispheres, rods, dumbbell-, acorn- or (like in the 
present study) snowman-shaped particles.[7] Besides, the 
integration of metal nanoparticles and silica materials in Janus 
or core-shell structures for detection applications has been 
reported in several studies.[8] 
Urea [(NH2)2CO] is a key molecule in human, animal and 
plant metabolism. It is a major component of blood plasma and 
urine and its determination is of considerable interest in clinical 
and agricultural settings.[9] In humans, urea is synthesized in the 
livers for the removal of ammonia generated from the 
breakdown of proteins and amino acids. From the liver, urea is 
transported by the blood to the kidneys and finally excreted in 
urine. In plasma, urea normal levels are from 2.5 mM to 7.5 mM 
and concentrations above this range can be indicative of renal 
dysfunctions, liver disease or dietetic problems.[10] On the other 
hand, urea has been identified amongst the most common 
chemicals used in milk adulteration, especially in developing 
countries.[11] It is added with the aim of increasing the solid non-
fat content determined by conventional tests and consumption of 
milk adulterated with urea can cause serious health problems.  
Furthermore, urea levels in cattle milk are a useful parameter to 
control animal health, and levels above 40 mg·dL-1 (6.6 mM) can 
be indicative of disease.[12] In the last 3 years, the development 
of simple methodologies for urea detection has attracted 
considerable attention and several studies have been reported 
(see Table SI-1),[13] most of them based on electrochemical 
sensing.[13a-j] Whereas previous electrochemical sensors have 
generally required two enzymes (urease and glutamate 
dehydrogenase) and mediators (e.g., NADH, L-glutamate, 
ferrocene) to complete electron transfer to the electrode,[14] 
recent studies aim to reduce complexity and the number of 
chemicals needed by using polymer composites and graphene 
modified electrodes.[13a-j] Furthermore, a colorimetric method 
based on the aggregation of unmodified gold nanoparticles with 
a detection limit of 20 mM,[13k] and a urea probe based on the 
Figure 2. Representation of the design and sensing performance of the nanosensor S1. Inset: TEM image of Janus Au-MSNPs. 






magnetization of iron nanoparticles in oil-in-water emulsions 
have been reported.[13l] Despite these advances, the 
development of simple methods for urea sensing in complex 
matrices (i.e. plasma, milk) to reduce analysis time and avoid 
the use of sophisticated equipment remains a topic of interest. 
Results and Discussion 
The design and sensing paradigm of the urea nanosensor 
(S1) based on the release of labelled-oligonucleotide from 
Janus-type Au-mesoporous silica nanoparticles mediated by an 
integrated enzymatic unit (urease) are depicted in Figure 2. The 
silica face, in the Janus nanoparticles, is functionalized with 
amino moieties (positively charge at neutral pH) to which 
oligonucleotides attach via electrostatic interactions.[15] The 
oligonucleotide strand contains 20 nucleotides and is labelled 
with a fluorescent dye (Alexa Fluor 647) on its 5’-end. Moreover, 
the gold face is used for immobilizing urease enzyme. The 
nanosensor produces a strong fluorescent signal in the 
presence of urea as a consequence of its recognition by the 
enzyme and transformation into ammonia and CO2. This induces 
a local decrease of the pH and deprotonation of the amino 
moieties on the silica face which results in the release of the 
labelled-oligonucleotide to the solution. 
In order to prepare the nanosensor, firstly, mesoporous 
silica nanoparticles (MSNPs) were synthesized by condensation 
of tetraethyl orthosilicate in alkaline media using n-
cetyltrimethylammonium bromide (CTAB) micelles as a template. 
Gold nanoparticles (AuNPs) were synthesized by reduction of 
Au(III) with sodium citrate. Next, MSNPs were partially 
functionalized with (3-mercaptopropyl)trimethoxysilane by 
confinement at the interface of an emulsion between paraffin 
wax and an aqueous phase, and AuNPs were then attached to 
MSNPs by the formation of Au-S bonds with thiols on the silica 
surface. The paraffin wax was removed by washing the 
nanoparticles with CHCl3, which yielded the Janus Au-
mesoporous silica nanoparticles (Au-MSNPs).[16] Then, the gold 
face was functionalized by treatment with 3-mercaptopropionic 
acid and afterward the silica surface was functionalized with 
amino moieties by treatment with an excess of (3-
aminopropyl)triethoxysilane. The resulting solid (S0) was stirred 
in a solution of a labelled oligonucleotide ((Alexa Fluor 647)-5’-
AATGCTAGCTAATCAATCGGG-3’) in phosphate buffer at pH 
7.5 for 30 min, washed, and further functionalized with urease by 
coupling the enzyme with carboxylic groups on the gold face via 
the use of ethyl(dimethylaminopropyl)carbodiimide (EDC) and N-
hydroxysuccinimide (NHS). This process finally yielded the 
sensing nanodevice S1 (Figure 1), which was kept in the 
refrigerator in phosphate buffer solutions (pH 7.5) until use. 
The prepared materials were characterized using standard 
procedures (see Supporting Information). TEM images (inset in 
Figure 1 and Figure SI-1) confirmed the linkage between 
MSNPs nanoparticles (ca. 80-100 nm) and AuNPs (ca. 20 nm) 
yielding the Janus-type Au-MS structure. Absorption spectra 
showed the characteristic gold surface plasmon resonance at 
525 nm for AuNPs, with a red-shift to 532 nm for Au-MSNPs 
due to the increase in the refractive index around the gold 
surface induced by the coupling with the mesoporous silica 
(Figure SI-2). Additionally, low-angle powder X-ray diffraction 
(PXRD) patterns (Figure SI-3) of the MSNPs and Au-MSNPs 
showed the (100) reflection peak that is characteristic of 
mesoporous silica materials. At high angles, the PXRD pattern 
of the Au-MSNPs Janus colloids showed the cubic gold (111), 
(200), (220), and (311) peaks which confirmed the presence of 
gold nanocrystals observed by TEM. Conservation of low- and 
high-angles peaks in S0 confirmed that the functionalization 
processes did not damage the 3D structure. The total surface 
area of starting MSNPs was 1299.86 m2·g-1, determined from N2 
adsorption-desorption isotherms, and reduced to 974.28 m2·g-1 
for Au-MSNPs due to the incorporation of non-porous gold 
nanoparticles (Figure SI-4). The zeta potential of the MSNPs 
and Au-MSNPs was -39.9 and -39.4 mV (at pH 7.5) respectively 
and for S0 the total charge was reduced (-16 mV) due the 
functionalization of the silica face with aminopropyl groups. For 
the final nanodevice S1, the negative charge increased to -30 
mV due to the attachment of oligonucleotide strands on the silica 
face and to the immobilization of urease on the gold surface. 
From dynamic light scattering measurements, the hydrodynamic 
diameter for the sensing nanoparticles S1 was determined to be 
111±20 nm (Figure SI-5). From elemental analysis of S0, the 
amount of anchored aminopropyl moieties was determined to be 
1.6 mmol per gram of solid. The amount of labelled-
oligonucleotide on the final nanodevice S1 was 2 µmol per gram 
of solid, as determined by fluorescence. The activity of 
immobilized urease on S1 was 820 U·g-1, as determined using a 
standard assay (see Experimental Section and Figure SI-6), 
which corresponds to 12.7 mg of commercial enzyme per g of 
S1. 
To assess the feasibility of the proposed nanosensor, we 
first monitored the release of labelled-oligonucleotide from S1 in 
aqueous media in the absence and presence of urea. For these 
experiments, S1 aliquots were brought to a concentration of 0.3 
mg·mL-1 in phosphate buffer solution (PBS, pH 7.5) containing 
either 0 or 5 mM of urea and stirred at room temperature (25 °C). 
At scheduled times, aliquots were taken, centrifuged to remove 
the nanoparticles and the release of labelled-oligonucleotide to 
the solution was evaluated by measuring the emission band of 
Alexa Fluor 647 at 664 nm (λexc = 649 nm). The oligonucleotide 
release kinetics are displayed in Figure 2. As can be seen, in the 
absence of urea, the fluorescence emission was negligible since 
amino moieties on the silica surface are protonated (pka = 9.6)
[17] 
and the oligonucleotide remains attached by the formation of 
electrostatic interactions.[18] In contrast, in the presence of urea a 
strong fluorescence signal was observed due to the release of 
labelled-oligonucleotide from S1 to the solution. This emission 
enhancement was ascribed to the recognition of urea by the 
enzymatic unit on S1, which catalysed the formation of carbon 
dioxide and ammonia. In turn, ammonia induced the 
deprotonation of amino moieties on S1, which broke the 
electrostatic interactions with phosphate groups and produced 
the release of labelled-oligonucleotide. Besides, an increase in 
the pH of the media was observed as a result of ammonia 
formation. In order to confirm the sensing mechanism, we 






checked that the fluorescence of (Alexa Fluor 647)-labelled 
oligonucleotide alone was not affected by the pH of the media or 
the presence of urea. In addition, urea did not induce any 
increase in fluorescence when Janus nanoparticles containing 




Figure 3. Labelled-oligonucleotide release from S1 determined by measuring 
emission at 664 nm (λexc = 649 nm) in water solutions (PBS, pH 7.5) in the 
absence (black curve) and in the presence (red curve) of urea (5 mM). 
 
Figure 4. Emission at 664 nm (λexc = 649 nm) associated with the release of 
labelled-oligonucleotide release from S1 as a function of urea concentration in 
water solutions (PBS, pH 7.5) after 10 min of incubation. 
In a next step, we studied the response of the nanosensor 
S1 as a function of urea concentration. S1 nanoparticles were 
suspended in PBS (0.3 mg·mL-1, pH 7.5) with different 
concentrations of urea, incubated for 10 min and afterward the 
fluorescence of the released labelled-oligonucleotide was 
measured. As can be seen in Figure 4, a gradual enhancement 
in fluorescence was observed upon increasing the amount of 
urea. Particularly, a linear increase occurred in the range 1.25- 
8.75 mM and a limit of detection of 0.5 mM was calculated from 
the calibration curve. In terms of clinical applications, the linear 
range of nanosensor S1 confers it a competitive basis to monitor 
urea within the normal clinical range found in blood plasma (2.5-
7.5 mM). Additionally, the nanosensor S1 may also be employed 
for the analysis of higher urea concentrations, such as that 
found in plasma of patients with renal problems or the normal 
concentrations in urine (700-130 mM),[19] by simply performing 
dilutions of the samples. 
In a further step, we confirmed the selectivity of the 
sensing nanodevice by evaluating the response of S1 in the 
presence of other biomolecules such as glucose, creatinine and 
uric acid at physiological concentrations. For these experiments, 
S1 (0.3 mg·mL-1) was suspended in aqueous solutions at pH 7.5 
(PBS) in the presence of each chemical and incubated for 10 
minutes. Then, the fluorescence of the released labelled-
oligonucleotide was determined. As can be seen in Figure 5, 
these biomolecules did not produce any appreciable increase in 
fluorescence which indicated that the oligonucleotide remained 
attached to S1. In an additional experiment, the response of S1 
was tested in a solution containing a mixture of these potential 
interferences and urea, and a clear fluorescent signal was 
observed indicating the selective recognition of urea with the 
subsequent release of oligonucleotide in this complex mixture. 
 
 
Figure 5. Emission at 664 nm (λexc = 649 nm) associated with the labelled-
oligonucleotide release from S1 in the presence of different biomolecules at 
physiological concentrations (glucose (5 mM), creatinine (80 µM), uric acid 
(0.3 mM)), in the presence of urea (5 mM) and in a mixture of these potential 
interferents and urea (5 mM). 
Encouraged by the above mentioned results, we decided 
to evaluate the potential use of nanosensor S1 for the detection 
of urea in real human blood samples. Blood samples were 
obtained from a healthy volunteer, and were centrifuged to 
separate the plasma (see Experimental Section and Figure SI-7 
for details). In order to perform the analysis, 15 µL of plasma 
samples spiked with different amounts of urea were added over 
135 µL of a S1 suspension (0.3 mg·mL-1) and incubated for 10 
minutes. After this, aliquots were centrifuged to eliminate the 
nanoparticles and the fluorescence of the supernatant was then 






measured. Remarkably, as can be seen in Figure 6, a significant 
and proportional increase in fluorescence was observed as a 
function of the urea concentration in plasma. The analysed 
range was selected taking into account that in patients with renal 
dysfunctions urea concentration in blood is in the 20-50 mM 
range and that it decreases to less than 10 mM after dialysis.[20] 
The obtained response clearly indicated that plasma samples 
with abnormal levels of urea can be analysed by adding small 
amounts of the sample (15 µL) over a suspension containing S1. 
Additionally, from the intercept of the resulting calibration line 
(y=60.93 + 17.54x) with the x-axis, a urea concentration of 3.5 
mM in the original (non-spiked) blood was determined, which is 
a normal value for a healthy person. Furthermore, we used this 
calibration to estimate the concentration of two samples spiked 
with urea (with a final concentration of 23.5 mM and 43.5 mM 
respectively). Using the procedure described above, urea 
concentration was determined to be 26.4 and 42.6 mM 
respectively, with recovery ratios of 112 and 98 %, respectively. 
 
 
Figure 6. Emission at 664 nm (λexc = 649 nm) as a function of spiked urea 
concentration in human blood plasma associated with the release of labelled-
oligonucleotide from S1 after 10 min of incubation. 
Finally, we tested the potential use of S1 to detect urea in 
adulterated milk. For these experiments, we used commercial 
milk that had been either spiked or not with urea (20 mM). In a 
similar way to the experiments performed in human blood, 15 µL 
of milk (previously centrifuged using centrifugal filters to remove 
turbidity) were added over aqueous solutions of S1 (0.3 mg·mL-
1) and stirred for 10 minutes at room temperature. As can be 
seen in Figure 7, a remarkable difference in the supernatant 
fluorescence was observed between adulterated and non-
adulterated milk samples. This fact points out the ability of S1 to 
identify abnormal urea levels in milk (indicative of adulteration). 
 
 
Figure 7. Discrimination between adulterated (containing 20 mM of urea) and 
non-adulterated milk using S1. Emission at 664 nm (λexc = 649 nm) associated 
with the release of labelled-oligonucleotide release from S1 after 10 min of 
incubation with adulterated and non-adulterated milk. 
Conclusions 
 In summary, we report here a new nanoarchitectonics-
based approach for the design of optical probes that combine (i) 
an enzymatic receptor subunit, (ii) a hybrid signalling subunit 
(consisting of labelled-reporter molecules attached to a silica 
surface by labile interactions), and (iii) a mechanism of 
communication between the two sites founded on the production 
of chemical messengers by the enzymatic subunit that induces 
the detachment of reporter molecules from the silica surface. As 
a proof-of-concept, the design, preparation and characterization 
of a nanodevice for urea detection based on the release of 
fluorescent-oligonucleotide from enzyme-functionalized Janus 
Au-mesoporous silica nanoparticles has been presented. The 
nanosensor consists of Janus-type Au-mesoporous silica 
nanoparticles functionalized with a fluorescent-oligonucleotide 
(on the silica face via electrostatic interactions with previously 
anchored 3-aminopropyl moieties) and with urease (by coupling 
the enzyme with carboxylic groups on the gold face). The 
sensing mechanism is based on the recognition of urea by the 
enzymatic unit and the production of ammonia (chemical 
messenger), which induces the detachment of the fluorescent 
oligonucleotide strand from the silica surface. The nanosensor 
was able to detect the presence of urea and a linear response 
was observed in the 1.25-8.75 mM concentration range, which 
covers the normal clinical range in plasma (from 2.5 mM to 7.5 
mM). We demonstrated the applicability of the nanosensor for 
the detection of urea in human blood samples and for the 
identification of adulterated milk. Regarding the sensing of urea, 
this fluorescent nanosensor represents a simple and novel 
alternative to previously reported electrochemical and optical 
sensors and allows urea detection in real samples. 
Notwithstanding, given the knowledge acquired in the field of 
chemosensors and supramolecular chemistry in the design of 
labile linkages that can be broken by common enzymatic 
products (e.g. H3O+, OH-, H2O2, nucleophiles, etc.), this 






approach could open new directions towards the development of 
novel optical sensors. Furthermore, mesoporous silica offers the 
additional possibility of loading an additional cargo (dye or 
fluorophore) in the inner of the pores and will allow the 
development multisignalling nanosensors that combine the 
detachment of labelled-reporters from the external surface with 
the release of cargos from the pores. From a broad perspective, 
we believe that these results could inspire the development of 
nanodevices based on the combination of enzymatic effectors 
and the detachment of different reporter species for the design 
of easy-to-use detection kits of analytes of biomedical and 
environmental interest. 
Experimental Section 
Chemicals. Tetraethyl orthosilicate (TEOS), n-cetyltrimethylammonium 
bromide (CTABr), sodium hydroxide (NaOH), (3-
mercaptopropyl)trimethoxysilane, hydrogen tetrachloroaurate(III) 
(HAuCl4·3H2O), sodium citrate tribasic dihydrate, paraffin wax, 3-
mercaptopropionic acid, urease from Jack Beans (type IX), (3-
aminopropyl)triethoxysilane, N-hydroxysuccinimide (NHS), N-(3-
dimethylaminopropyl)-NI-ethylcarbodiimide hydrochloride (EDC), urea, 
glucose, creatinine hydrochloride, uric acid, and urease assay kit were 
purchased from Sigma-Aldrich. Sodium chloride, potassium chloride, 
sodium dihydrogen phosphate monohydrate, potassium dihydrogen 
phosphate, disodium hydrogen phosphate heptahydrate, ethanol, 
chloroform and acetonitrile were provided by Scharlau. Oligonucleotide 
(Alexa Fluor 647)-5’-AATGCTAGCTAATCAATCGGG-3’ was provided by 
Thermo Fisher. 
General methods. Powder X-ray diffraction (PXRD), transmission 
electron microscopy (TEM), N2 adsorption-desorption isotherms, UV-
visible and fluorescence spectrophotometries, dynamic light scattering 
(DLS), and elemental analysis were employed for materials 
characterization. PXRD measurements were performed on a Seifert 
3000TT diffractometer using CuKα radiation. TEM images were acquired 
using a JEOL TEM-1010 Electron microscope. N2 adsorption-desorption 
isotherms were recorded using a Micromeritics TriStar II Plus automated 
analyzer. UV-visible spectra were recorded with a JASCO V-650 
Spectrophotometer. Fluorescence measurements were carried out on a 
JASCO FP-8500 Spectrophotometer. DLS experiments were performed 
with a ZetaSizer Nano ZS (Malvern). Elemental analysis was performed 
using a CE Instrument EA-1110 CHN Elemental Analyzer. 
Synthesis of mesoporous silica nanoparticles (MSNPs). First, 1.00 g 
(2.74 mmol) of n-cetyltrimethylammonium bromide (CTABr) was 
dissolved in 480 mL of deionized water. Next, 3.5 mL of a 2 mol·L-1 
NaOH were added solution and the temperature was increased to 80 °C. 
Then, 5.0 mL of TEOS (22.4 mmol) were added to the stirring solution. 
The mixture was further stirred for 2 hours  at 80 °C which yielded a 
white precipitate. Afterward, the solid was isolated by centrifugation, 
washed several times with water and dried at 70 °C overnight. Finally, 
CTABr was removed by heating the solid at 550 °C (in an oxidant 
atmosphere for 5 hours) which yielded the starting MSNPs. 
Synthesis of gold nanoparticles (AuNPs). Gold nanoparticles were 
obtained by reduction of Au(III) with citrate. First, 100 mL of 
HAuCl4·3H2O solution (1.16 x10
-2  %) were refluxed under magnetic 
stirring. Then, 1.57 mL of 1% sodium citrate solution were added to 
induce the formation 20 nm gold nanoparticles. The initially faint yellow 
colour turned to blue-black and finally to red wine in a few minutes. After 
10 minutes refluxing, the colloidal suspension was let to cool at room 
temperature. This process was repeated four times. 
Synthesis of Janus Au-MSNPs. 180 mg of MSNPs were dispersed in 9 
mL of aqueous solution (6.7 % ethanol) and n-cetyltrimethylammonium 
bromide (CTABr) was added for a 1 µM final concentration. The mixture 
was heated at 75 °C, and then 1 g of paraffin wax was added. Once the 
paraffin was melted, the mixture was vigorously stirred for 15 minutes 
using an Ultra-Turrax T-8 homogenizer (IKA). Afterward, the mixture was 
further stirred for 1 h and 75 °C using a magnetic stirrer. The resulting 
Pickering emulsion was then cooled to room temperature, mixed with 9 
mL of methanol and reacted with 180 µL of (3-
mercaptopropyl)trimethoxysilane for 3 hours. The solid was collected by 
centrifugation and washed twice with methanol. Then, the resulting 
MSNPs were dispersed in 68 mL of methanol and added over 400 mL of 
the as-synthesized AuNPs. The mixture was stirred overnight. Afterward, 
the solid was isolated by filtration and exhaustively washed with ethanol 
and with chloroform in order to remove the paraffin. The solid was dried 
at room temperature and ground. This process finally yielded the Janus 
Au-MSNPs. 
Synthesis of S0. A suspension of 30 mg of Au-MSNPs in 5 mL of 
acetonitrile was treated with 50 µL of 3-mercaptopropionic acid in order 
to functionalize the gold face. The mixture was stirred at room 
temperature for 1 hour. Afterward, nanoparticles were isolated by 
centrifugation, washed exhaustively with acetonitrile and dried at room 
temperature overnight.  The next day, the solid was suspended in 2.5 mL 
of acetonitrile and reacted with 60 µL of (3-aminopropyl)triethoxysilane 
for 5.5 hours in order to functionalize the mesoporous face with amino 
groups. The solid was isolated by centrifugation, washed once with 
acetonitrile and once with ethanol and was dried at room temperature. 
This process finally yielded the solid S0. 
Preparation of S1. In order to prepare the sensing nanodevice, 1 mg of 
S0 was dispersed in 450 µL of sodium phosphate buffer (pH 7.5, 50 mM) 
and mixed with 50 µL of labelled-oligonucleotide solution (100 µM). The 
solution was placed in a shaker at 37 °C for 30 minutes. Afterward, the 
excess of oligonucleotide was removed by centrifugation and the solid 
was mixed with 0.5 mg of urease, 0.35 mg of EDC and 0.35 mg of NHS 
in sodium phosphate buffer (500 µL, pH 7.5, 50 mM). The sample was 
placed in a shaker a 4 °C overnight. Finally, the nanoparticles were 
isolated by centrifugation, washed several times with buffer and kept in 
the refrigerator until use. 
Enzymatic assay. Urease activtiy of S1 was evaluated using a 
commercial kit provided by Sigma-Aldrich. It is based on measuring the 
ammonia produced by the enzymatic reaction using the Berthelot’s 
reagent (an alkaline solution of phenol and hypochlorite) which results in 
the formation of the colored indophenol blue.[21] First, samples are 
incubated 10 minutes with a urea solution, followed by stopping the 
reaction and further incubation for 30 minutes with the Berthelot’s 
reagent. Following the technical procedure, the absorbance at 670 nm for 
the ammonium standards was measured to obtain the calibration curve 
showed in Figure SI-6.  From the absorbance of indophenol blue 
obtained by incubation with S1 (0.01 mg·mL-1) or with commercial 
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t = incubation time of with urea (10 min) 






(A670)sample = Absorbance value for sample 
(A670)blank = Absorbance value for assay blank (0.06) 
Slope= slope of the calibration line in Figure SI-6 (0.0015 µM-1) 
C= concentration of the sample. 
The determined urease activity for S1 was 830 U·g-1 and for the 
commercial enzyme was 65333 U·g-1, from which an equivalent amount 
of 12.7 mg of enzyme per g of S1, was calculated. 
Sensing experiments. In a typical experiment, refrigerated solutions of 
S1 were brought to a concentration of 0.3 mg·mL-1 in aqueous solution 
(PBS, pH 7.5) containing the corresponding amount urea and were 
stirred at room temperature (25 °C) in a thermoshaker. Aliquots were 
taken at scheduled times, centrifuged (2 min) to remove the 
nanoparticles and then the emission of fluorescent-DNA at 664 nm was 
measured (λexc = 649 nm). On the other hand, human blood samples  
were obtained from a healthy volunteer thanks to the support of our 
university health centre. Red blood cells were separated from serum by 
centrifugation (10 min at 11000 rpm) and serum samples were further 
centrifuged (5 min, 11000 rpm) using Amicon Ultra-05 centrifugal filters 
units with Ultracel-10 membranes to remove proteins (see Figure SI-7). 
For analysis, 15 µL of serum spiked with the corresponding amount of 
urea were added over 135 μL of S1 aqueous solution (0.3 mg·mL-1). 
After 10 minutes of incubation, samples were centrifuged to remove the 
nanoparticles and the emission at 664 nm (λexc = 649 nm) was measured. 
Milk samples were also centrifuged (5 min, 11000 rpm) with Amicon 
Ultra-05 centrifugal filters units with Ultracel-10 membranes to remove 
turbidity and then 15 µL of sample were added over 135 μL of S1 
aqueous solution and incubated for 10 minutes before measuring the 
emission spectra.   
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We present a novel paradigm for the design of optical sensors based on 
nanodevices incorporating an enzymatic receptor subunit and a hybrid signalling 
subunit that communicate through chemical messengers. As a proof of concept, a 
urea nanosensor based on the release of Alexa Fluor 647-labelled oligonucleotide 
from urease-functionalized Janus Au-MSNPs (gold-mesoporous silica 
nanoparticles) has been developed. 
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